PSMA-617 | springermedizin.de

Springer Medizin

nach oben

Reactions Weekly

Erschienen in:

01.10.2016 | Case report

PSMA-617

Anaemia (first report) and thrombocytopenia: 3 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2016

Einloggen, um Zugang zu erhalten

Excerpt

Author Information

An event is serious (FDA MedWatch definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* requires intervention to prevent permanent impairment or damage

First published case report …

Anzeige

Kratochwil C, et al. PSMA-targeted radionuclide therapy of metastatic castration-resistant prostate cancer with 177Lu-Labeled PSMA-617. Journal of Nuclear Medicine 57: 1170-1176, No. 8, Aug 2016. Available from: URL: http://doi.org/10.2967/jnumed.115.171397 - GermanyCrossRefPubMed

Titel: PSMA-617
Anaemia (first report) and thrombocytopenia: 3 case reports
Publikationsdatum: 01.10.2016
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2016
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-016-21770-x